 |
||||||||
 |
|
 |
 |
 |
 |
 |
|
|
 |
Michael C. Diem - PartnerMike joined SR One in 2005 and is a Kauffman Fellow. He is currently a board director at Aileron Therapeutics, CalciMedica, Synovex, Trinity Biosystems and NuPathe, Inc. Other portfolio companies that he was responsible for included Protez Pharmaceuticals (acquired by NVS in 2008) and Metastatix, Inc. He has 9 years of clinical experience and completed his residency training at Duke University Medical Center. Mike has an MD from the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, and an MBA from Case Western Reserve University.
|
|